annual operating expenses:
$391.32M-$70.97M(-15.35%)Summary
- As of today (September 15, 2025), CRSP annual total operating expenses is $391.32 million, with the most recent change of -$70.97 million (-15.35%) on December 31, 2024.
- During the last 3 years, CRSP annual operating expenses has fallen by -$47.06 million (-10.73%).
- CRSP annual operating expenses is now -30.54% below its all-time high of $563.35 million, reached on December 31, 2022.
Performance
CRSP Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$84.21M-$2.83M(-3.26%)Summary
- As of today (September 15, 2025), CRSP quarterly total operating expenses is $84.21 million, with the most recent change of -$2.83 million (-3.26%) on June 30, 2025.
- Over the past year, CRSP quarterly operating expenses has dropped by -$10.59 million (-11.17%).
- CRSP quarterly operating expenses is now -52.55% below its all-time high of $177.46 million, reached on September 30, 2022.
Performance
CRSP quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CRSP Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.3% | -11.2% |
| 3 y3 years | -10.7% | -52.2% |
| 5 y5 years | +61.1% | +4.4% |
CRSP Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.5% | at low | -52.5% | at low |
| 5 y | 5-year | -30.5% | +61.1% | -52.5% | +111.0% |
| alltime | all time | -30.5% | +5804.9% | -52.5% | +111.0% |
CRSP Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $84.21M(-3.3%) |
| Mar 2025 | - | $87.04M(-8.8%) |
| Dec 2024 | $391.32M(-15.4%) | $95.44M(+0.7%) |
| Sep 2024 | - | $94.78M(-0.0%) |
| Jun 2024 | - | $94.80M(+6.2%) |
| Mar 2024 | - | $89.29M(-16.3%) |
| Dec 2023 | $462.29M(-17.9%) | $106.72M(+2.6%) |
| Sep 2023 | - | $104.06M(-10.0%) |
| Jun 2023 | - | $115.63M(-1.4%) |
| Mar 2023 | - | $117.24M(-1.4%) |
| Dec 2022 | $563.35M(+28.5%) | $118.88M(-33.0%) |
| Sep 2022 | - | $177.46M(+0.7%) |
| Jun 2022 | - | $176.15M(+3.1%) |
| Mar 2022 | - | $170.87M(+12.2%) |
| Dec 2021 | $438.38M(+23.5%) | $152.34M(+18.2%) |
| Sep 2021 | - | $128.85M(-116.9%) |
| Jun 2021 | - | -$762.62M(-765.8%) |
| Mar 2021 | - | $114.54M(+6.3%) |
| Dec 2020 | $354.98M | $107.76M(+16.6%) |
| Sep 2020 | - | $92.40M(+14.5%) |
| Jun 2020 | - | $80.69M(+9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $73.59M(-770.0%) |
| Dec 2019 | $242.85M(+49.8%) | -$10.98M(-92.1%) |
| Sep 2019 | - | -$139.16M(-353.1%) |
| Jun 2019 | - | $54.98M(+13.5%) |
| Mar 2019 | - | $48.42M(+7.1%) |
| Dec 2018 | $162.07M(+53.4%) | $45.23M(-8.5%) |
| Sep 2018 | - | $49.43M(+32.6%) |
| Jun 2018 | - | $37.29M(+38.1%) |
| Mar 2018 | - | $27.00M(-2877.5%) |
| Dec 2017 | $105.64M(+44.1%) | -$972.00K(-104.1%) |
| Sep 2017 | - | $23.57M(+10.6%) |
| Jun 2017 | - | $21.31M(+2.7%) |
| Mar 2017 | - | $20.74M(-18.0%) |
| Dec 2016 | $73.29M(+182.2%) | $25.31M(+73.2%) |
| Sep 2016 | - | $14.61M(-11.8%) |
| Jun 2016 | - | $16.56M(+42.1%) |
| Mar 2016 | - | $11.65M(+222.7%) |
| Dec 2015 | $25.98M(+292.0%) | - |
| Jun 2015 | - | $3.61M(-3.0%) |
| Mar 2015 | - | $3.72M |
| Dec 2014 | $6.63M | - |
FAQ
- What is CRISPR Therapeutics AG annual total operating expenses?
- What is the all time high annual operating expenses for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual operating expenses year-on-year change?
- What is CRISPR Therapeutics AG quarterly total operating expenses?
- What is the all time high quarterly operating expenses for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly operating expenses year-on-year change?
What is CRISPR Therapeutics AG annual total operating expenses?
The current annual operating expenses of CRSP is $391.32M
What is the all time high annual operating expenses for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual total operating expenses is $563.35M
What is CRISPR Therapeutics AG annual operating expenses year-on-year change?
Over the past year, CRSP annual total operating expenses has changed by -$70.97M (-15.35%)
What is CRISPR Therapeutics AG quarterly total operating expenses?
The current quarterly operating expenses of CRSP is $84.21M
What is the all time high quarterly operating expenses for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly total operating expenses is $177.46M
What is CRISPR Therapeutics AG quarterly operating expenses year-on-year change?
Over the past year, CRSP quarterly total operating expenses has changed by -$10.59M (-11.17%)